United States · FDA National Drug Code directory
Oxymorphone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64896-700_4f08b804-ef2d-4c9b-8553-c2bc7fa1fd71
- Product NDC
- 64896-700
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Oxymorphone hydrochloride
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130102
- Source listing expiry
- 20271231
Source-listed ingredients
- OXYMORPHONE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-01) · 64896-700-01
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-03) · 64896-700-03
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-08) · 64896-700-08
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-13) · 64896-700-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →